Preventive Maintenance Optimization for Pharmaceutical Plants

equipment modifications require change control and validation impact assessments; maintenance activities generate deviation investigations when they affect batch quality. In this environment, equipment failures cause batch deviations, product holds, FDA 483 observations, and consent decree risk. Our PM task analysis and interval optimization program specifically targets HVAC air handling units, lyophilizers, tablet presses, centrifuges, clean utility systems (WFI, clean steam), and packaging lines — the assets where early detection has the greatest impact on batch success rate and deviation closure time. We also account for strict change control requirements, adapting our measurement approach to maintain data quality despite these operating conditions.

Yes. Pharmaceutical facilities must comply with FDA 21 CFR Parts 210/211 cGMP, EU Annex 15 qualification, and ISPE GAMP 5 for computerized systems. Our PM task analysis and interval optimization program generates the condition documentation needed for cgmp-compliant maintenance documentation with audit trail, equipment qualification records, and calibration traceability. Beyond compliance, the condition data drives measurable improvements in batch success rate and deviation closure time by converting unplanned failures into scheduled repairs. Most pharmaceutical clients see meaningful reductions in batch deviations within the first 12 months of program implementation.